Sarcoidosis news: Immunologic frontiers for new immunosuppressive strategies
被引:13
作者:
论文数: 引用数:
h-index:
机构:
Agostini, C
Costabel, U
论文数: 0引用数: 0
h-index: 0
机构:Univ Padua, Dipartimento Med Clin & Sperimentale, I-35128 Padua, Italy
Costabel, U
论文数: 引用数:
h-index:
机构:
Semenzato, G
机构:
[1] Univ Padua, Dipartimento Med Clin & Sperimentale, I-35128 Padua, Italy
[2] Ruhrlandklin, D-25239 Essen, Germany
来源:
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY
|
1998年
/
88卷
/
02期
关键词:
D O I:
10.1006/clin.1998.4544
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Although the etiology of sarcoidosis is still unknown, it is now clear that the formation of the sarcoid granuloma is keenly regulated by a cascade of cytokines. Furthermore, several experimental data indicate a direct association between the release of cytokines and the development of lung fibrosis. In a recent meeting over 300 investigators convened to assess current knowledge in the held of sarcoidosis, vasculitis, and diffuse lung diseases. The meeting provided an overview on the complex networks between immunocompetent cells, cytokines, and mesenchymal cells setting the stage for the pathogenesis of granulomatous and vasculitic disorders. However, emphasis was given to the possibility of using innovative immunotherapies to target relevant cytokines or molecules involved in granuloma formation and the remodelling of lung tissue. (C) 1998 Academic Press.